Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hodgkin's disease.

C S Portlock

    The Medical Clinics of North America
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Significant advancements in Hodgkin

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Noninvasive Monitoring of Mantle Cell Lymphoma by Immunoglobulin Gene Next-Generation Sequencing in a Phase 2 Study of Sequential Chemoradioimmunotherapy Followed by Autologous Stem-Cell Rescue.

    Clinical lymphoma, myeloma & leukemia·2021
    Same author

    Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients.

    Leukemia & lymphoma·2016
    Same author

    Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2009
    Same author

    Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience.

    Annals of oncology : official journal of the European Society for Medical Oncology·2009
    Same author

    Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy.

    Annals of oncology : official journal of the European Society for Medical Oncology·2007
    Same author

    Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2007

    Area of Science:

    • Oncology
    • Hematology

    Background:

    • Hodgkin's disease treatment outcomes have dramatically improved over the last two decades.
    • The focus has shifted from cure possibility to optimizing treatment strategies for Hodgkin's disease.
    • Enhanced understanding of Hodgkin's disease biology is driving treatment evolution.

    Purpose of the Study:

    • To summarize current concepts in the biology of Hodgkin's disease.
    • To provide an overview of contemporary management strategies for Hodgkin's disease.
    • To discuss staging, treatment options, and therapy complications.

    Main Methods:

    • Review of current literature on Hodgkin's disease biology and treatment.
    • Synthesis of information regarding staging, therapeutic modalities, and adverse effects.

    Related Experiment Videos

  • Discussion of evolving treatment approaches based on biological insights.

    • Main Results:

    • Hodgkin's disease is increasingly curable, with a focus on achieving the best outcomes.
    • Continued progress in understanding disease biology supports the goal of curing all patients.
    • Comprehensive management strategies are evolving.

    Conclusions:

    • Curing all patients with Hodgkin's disease is an achievable goal.
    • Integrated approaches combining biological understanding and advanced therapies are key.
    • Careful consideration of staging, treatment, and complications is essential for optimal patient care.